Exit: Lifebound Medical Device was sold to the American Bard Medical Device for about $ 60 million

The Lifebound Medical Device Company, which develops a hernia fusion network (Hernia Mesh), was sold to Bard Medical Device, now part of the US medical supplies provider, Keton Dickinson (BD). The amount of the deal is several tens of millions of dollars, similar to the amount it has raised to date - about $ 60 million.
The main company investors since its inception in 2007 have been the Pitango Fund and biomass investor Robert Taub, who co-founded a company dealing in a similar technology - Omrix, sold to Johnson & Johnson for $ 438 million. Taub chose to invest in Lipbound out of deep familiarity with the technology, although the products might have been competitors. Johnson & Johnson, which, as stated, acquired Omrix, sought to restore its success in partnering with Taub around bleeding-stop products and also invested in the company, thinking the products might be complementary.
Lipbound was founded in 2007 by Yishai Aether - a medical engineer and entrepreneur who has since founded several companies in various biomedical fields, including biochange and outsenses, and Oren Price Bloom - also a biomedical engineer and biomechanics researcher who has since founded the medical device company Ossio. The two have previously said that they decided to start a company to stop bleeding after exposure to soldiers' injuries in the Second Lebanon War. When the company was established, it became clear that the product was more suited to the more common damage of the intestines and leaks from the intestine after part of the intestine.
In a clinical trial in about 70 patients, the product achieved good results and was recorded for marketing in Europe. Johnson & Johnson, which invested in the company, was interested at some point in its acquisition, but the deal did not come to fruition.